- FNestlé and Novartis rethink role in Turkey ad campaignft.com
- Novartis’ Gilenya Patent Invalidated as Obviousjdsupra.com
- Justices Hear Dispute Over Lower-Cost Biotech Drugs Salesmemphisdailynews.com
- Justices hear dispute over lower-cost biotech drugs salesThe Salt Lake Tribune
- U.S. Supreme Court hears dispute over lower-cost biotech drugs salesDenver Post
- 3 Vital Force For Today's Business World According to Elon MuskInc.
- Science37 aims to democratize clinical research with a fresh $29 million in growth fundingTechCrunch
- Swiss drugs giant Novartis posts 15 percent drop in 1Q netseattletimes.com
- EU drugmakers urge June decision on new location for bloc’s watchdogtimesofmalta.com
- MAmgen likely aiming to meet, not beat, first-quarter earnings expectationsmarketwatch.com
- MIT Media Lab Hands You a Compass (Not a Map) for Future SuccessInc.
- Remedy for Threat to US Pharmaceutical Industry's ProfitabilityForbes
- Oestrogen patch shortage 'devastating' disruption to HRT treatment for womenSydney Morning Herald
- BInternational Marketing – Marketing Papersbwlxwv.cuencaproperties.com
- BPittsfield: Annual MS Walk slated April 29berkshireeagle.com
- San Carlos shuttle for commuters taking off: City officials and local business owners hopeful program aiming to alleviate traffic congestion issues will sticksmdailyjournal.com
- Greece investigates Swiss pharma for briberythelocal.ch
- ZBetter ways to conclude a paperztgee.restauranteatico.es
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.